Studies have experimentally confirmed that the impact of ac4C in esophageal cancer could influence the development and progression of the disease by targeting epidermal growth factor receptor (EGFR) (Fig. 1D) [72]. The gene discussed is EGFR; the disease is esophageal cancer.